ChemoMetec Financials
| CHEMM Stock | DKK 285.20 2.40 0.83% |
ChemoMetec |
Understanding current and past ChemoMetec Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ChemoMetec's financial statements are interrelated, with each one affecting the others. For example, an increase in ChemoMetec's assets may result in an increase in income on the income statement.
The data published in ChemoMetec's official financial statements usually reflect ChemoMetec's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ChemoMetec AS. For example, before you start analyzing numbers published by ChemoMetec accountants, it's critical to develop an understanding of what ChemoMetec's liquidity, profitability, and earnings quality are in the context of the Life Sciences Tools & Services space in which it operates.
Please note, the presentation of ChemoMetec's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ChemoMetec's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ChemoMetec's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ChemoMetec AS. Please utilize our Beneish M Score to check the likelihood of ChemoMetec's management manipulating its earnings.
ChemoMetec Stock Summary
ChemoMetec competes with Ambu AS, and Zealand Pharma. ChemoMetec AS engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company was founded in 1997 and is headquartered in Allerd, Denmark. ChemoMetec operates under Medical Equipment classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 155 people.| Foreign Associate | USA |
| Instrument | Denmark Stock View All |
| Exchange | Copenhagen Exchange |
| ISIN | DK0060055861 |
| Business Address | Gydevang 43, Allerd, |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | chemometec.com |
| Phone | 45 48 13 10 20 |
| Currency | DKK - Danish Krone |
You should never invest in ChemoMetec without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ChemoMetec Stock, because this is throwing your money away. Analyzing the key information contained in ChemoMetec's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
ChemoMetec Key Financial Ratios
Generally speaking, ChemoMetec's financial ratios allow both analysts and investors to convert raw data from ChemoMetec's financial statements into concise, actionable information that can be used to evaluate the performance of ChemoMetec over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that ChemoMetec AS reports annually and quarterly.ChemoMetec Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ChemoMetec's current stock value. Our valuation model uses many indicators to compare ChemoMetec value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ChemoMetec competition to find correlations between indicators driving ChemoMetec's intrinsic value. More Info.ChemoMetec AS is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies reporting about 0.64 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ChemoMetec AS is roughly 1.56 . Comparative valuation analysis is a catch-all model that can be used if you cannot value ChemoMetec by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ChemoMetec's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ChemoMetec's earnings, one of the primary drivers of an investment's value.ChemoMetec AS Systematic Risk
ChemoMetec's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ChemoMetec volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on ChemoMetec AS correlated with the market. If Beta is less than 0 ChemoMetec generally moves in the opposite direction as compared to the market. If ChemoMetec Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ChemoMetec AS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ChemoMetec is generally in the same direction as the market. If Beta > 1 ChemoMetec moves generally in the same direction as, but more than the movement of the benchmark.
About ChemoMetec Financials
What exactly are ChemoMetec Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include ChemoMetec's income statement, its balance sheet, and the statement of cash flows. Potential ChemoMetec investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although ChemoMetec investors may use each financial statement separately, they are all related. The changes in ChemoMetec's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ChemoMetec's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze ChemoMetec Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as ChemoMetec is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of ChemoMetec has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if ChemoMetec's financials are consistent with your investment objective using the following steps:- Review ChemoMetec's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand ChemoMetec's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare ChemoMetec's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if ChemoMetec's stock is overvalued or undervalued.
ChemoMetec April 19, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ChemoMetec help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ChemoMetec AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of ChemoMetec AS based on widely used predictive technical indicators. In general, we focus on analyzing ChemoMetec Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ChemoMetec's daily price indicators and compare them against related drivers.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 45.71 | |||
| Value At Risk | (5.60) | |||
| Potential Upside | 6.17 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ChemoMetec AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for ChemoMetec Stock analysis
When running ChemoMetec's price analysis, check to measure ChemoMetec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ChemoMetec is operating at the current time. Most of ChemoMetec's value examination focuses on studying past and present price action to predict the probability of ChemoMetec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ChemoMetec's price. Additionally, you may evaluate how the addition of ChemoMetec to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |